Skip to main content
Sign In

Ana Belen Oton, MD

Associate Professor, Division of Medical Oncology

 Oton Bio Photo

Education: MD

Medical School-University Central of Venezuela at Caracas. June 1998


Dr. Oton joined the faculty of the University of Colorado Denver in July 2007. She is  fluent in English and Spanish.


Dr Ana B. Oton is an Associate Professor of Medical Oncology at the University of Colorado and Chair of the Cancer Committee at Denver Health Medical Center since 2012. She completed her fellowship training in Hematology-Oncology at the University of Pittsburgh. In 2007, she joined the University of Colorado Denver, Division of Medical Oncology in a dual appointment with Denver Health Medical Center as medical Oncologist and Hematologist. She devotes her time between clinical, teaching and research activities. She is currently the Director of the Clinical Trials Program of the Division of Hematology-Oncology at Denver Health Medical Center. Her research interests are new drug development in the field of thoracic malignancies and palliative care. She is fully committed to global education and actively collaborates with ASCO, ASH and HVO in educational activities around the world in countries like: Bolivia, Mexico, Oman, Argentina, Brazil, India and Uganda.

Invited Lectureships and Seminars


July 24-27, 2013       “Train the Trainer”
“Multidisciplinary Management of Lung Cancer”
                             “Adjuvant Treatment in Colon Cancer”
                             “Neoadjuvant  Treatment in Rectal Cancer”
                             Multidisciplinary Cancer Management Course, ASCO & Oncovida
II Curso International del Manejo Multidisciplinario del Cancer,
La Paz, Bolivia
July 5-6, 2013          “The Role of the Medical Oncologist in the Management of Lung Cancer”
Multidisciplinary Lung Cancer Management Workshop
Mexico City, Mexico
May 9-10 2013         “Management of Patients with Lung Cancer. The Era of ALK”
VIII Conference Buenos Aires, IV Conference LatinoAmericana, Enfoque Multidisciplinario de Cancer de Pulmon, Buenos Aires, Argentina
February 2013         “Efatutazone in NSCLC”
                             13th Annual Targeted Therapies, IASLC, Santa Monica, CA
                             “AZD6244 and Docetaxel in Lung Cancer”
                             13th Annual Targeted Therapies, IASLC, Santa Monica, CA
                             “Dacomitinib and Crizotinib, Phase I”
                             13th Annual Targeted Therapies, IASLC, Santa Monica, CA
January 2013           “Management of Patients on Crizotinib”,
                             III Cumbre de Actualizacion en Medicina de Alta Especialidad 2013, Educational Activity for Oncologists, Pulmonologists and Pathologists, Riviera Maya, Mexico
                             “Treatment of Early Stages of Lung Cancer”,
                             Medical Oncology Fellowship Lecture Series
                             Department of Hematology/Oncology University of Colorado Denver, Aurora, CO


PubMed Articles